These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 9915733)

  • 21. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
    Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure.
    MacDowall P; Kalra PA; O'Donoghue DJ; Waldek S; Mamtora H; Brown K
    Lancet; 1998 Jul; 352(9121):13-6. PubMed ID: 9800739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible.
    Devoy MA; Tomson CR; Edmunds ME; Feehally J; Walls J
    J Intern Med; 1992 Dec; 232(6):493-8. PubMed ID: 1474349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin converting enzyme inhibitor-induced renal dysfunction: recommendations for prevention.
    Cooke HM; De Besse A
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):65-70. PubMed ID: 8004361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of acute renal failure caused by angiotensin converting enzyme inhibitors.
    Wynckel A; Ebikili B; Melin JP; Randoux C; Lavaud S; Chanard J
    Am J Hypertens; 1998 Sep; 11(9):1080-6. PubMed ID: 9752893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin-angiotensin system inhibitors.
    Terano C; Ishikura K; Miura M; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Ando T; Honda M
    Eur J Pediatr; 2016 May; 175(5):631-7. PubMed ID: 26687571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physicians make different decisions from nephrologists at serum creatinine 2.0 mg/dl.
    Tamba K; Kusano E; Tabei K; Kajii E; Asano Y
    Clin Exp Nephrol; 2009 Oct; 13(5):447-451. PubMed ID: 19387767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study.
    Schmidt M; Mansfield KE; Bhaskaran K; Nitsch D; Sørensen HT; Smeeth L; Tomlinson LA
    BMJ; 2017 Mar; 356():j791. PubMed ID: 28279964
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute kidney injury during treatment with high-dose cloxacillin: a report of 23 cases and literature review.
    Lavergne A; Vigneau C; Polard E; Triquet L; Rioux-Leclercq N; Tattevin P; Golbin L
    Int J Antimicrob Agents; 2018 Sep; 52(3):344-349. PubMed ID: 29665445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Optimization of systolic heart failure treatment by general practitioners after hospital discharge: Are guidelines applied?].
    Msadek S; De Lauzun I; Diarova J; Sauvion D; Gandolfini MP; Beloued J; Digne F; Krapf L
    Ann Cardiol Angeiol (Paris); 2019 Oct; 68(4):195-200. PubMed ID: 31253348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.
    Márquez PHP; Torres OH; San-José A; Vidal X; Agustí A; Formiga F; López-Soto A; Ramírez-Duque N; Fernández-Moyano A; Garcia-Moreno J; Arroyo JA; Ruiz D;
    Drugs Aging; 2017 Jun; 34(6):453-466. PubMed ID: 28432600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme inhibitor-induced renal failure: causes, consequences, and diagnostic uses.
    Hricik DE; Dunn MJ
    J Am Soc Nephrol; 1990 Dec; 1(6):845-58. PubMed ID: 2103846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute renal failure, renal artery stenosis and angiotensin-converting enzyme (ACE) inhibitor].
    Svarstad E; Hultstrøm D; Jensen D; Jenssen G; Gravendeel J; Iversen BM
    Tidsskr Nor Laegeforen; 2001 Jun; 121(15):1784-8. PubMed ID: 11464681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
    St Peter WL; Odum LE; Whaley-Connell AT
    Pharmacotherapy; 2013 May; 33(5):496-514. PubMed ID: 23576066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-converting enzyme inhibitors in diabetics with hypertension--a cautionary note.
    Mohamed AS; Yaqoob M; Bell GM
    Nephron; 1990; 55(1):83-4. PubMed ID: 2352582
    [No Abstract]   [Full Text] [Related]  

  • 37. Nephrotoxicity in the elderly due to co-prescription of angiotensin converting enzyme inhibitors and nonsteroidal anti-inflammatory drugs.
    Adhiyaman V; Asghar M; Oke A; White AD; Shah IU
    J R Soc Med; 2001 Oct; 94(10):512-4. PubMed ID: 11581344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute failure of transplanted kidney after administration of angiotensin converting enzyme inhibitors (iACE)].
    Rell K; Serafinowicz A; Gaciong Z; Michnowska M; Lao M
    Pol Arch Med Wewn; 1993 May; 89(5):405-9. PubMed ID: 8367375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The AHCPR guidelines on heart failure: comparison of a family medicine and an internal medicine practice with the guidelines and an educational intervention to modify behavior.
    Chodoff P; Bischof RO; Nash DB; Laine C
    Clin Perform Qual Health Care; 1996; 4(4):179-85. PubMed ID: 10162148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perioperative management of patients treated with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a quality improvement audit.
    Vijay A; Grover A; Coulson TG; Myles PS
    Anaesth Intensive Care; 2016 May; 44(3):346-52. PubMed ID: 27246933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.